z-logo
open-access-imgOpen Access
Mucocutaneous Leishmaniasis: Knowledge, Attitudes, and Practices Among Paraguayan Communities, Patients, and Health Professionals
Author(s) -
Mónica Ruoti,
Rolando Oddone,
Nathalie Lampert,
Elizabeth Orué,
Michael A. Miles,
Neâl Alexander,
Andrea M. Rehman,
Rebecca Njord,
Stephanie Shu,
Susannah Brice,
Bryony Sinclair,
Alison Krentel
Publication year - 2013
Publication title -
journal of tropical medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 30
eISSN - 1687-9694
pISSN - 1687-9686
DOI - 10.1155/2013/538629
Subject(s) - mucocutaneous zone , leishmania braziliensis , medicine , health professionals , transmission (telecommunications) , leishmaniasis , logistic regression , cutaneous leishmaniasis , family medicine , environmental health , immunology , disease , health care , electrical engineering , engineering , economics , economic growth
Cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL) due to Leishmania (V.) braziliensis are endemic in Paraguay. We performed a series of knowledge, attitudes, and practice (KAP) surveys simultaneously with individuals in endemic communities in San Pedro department ( n = 463), health professionals ( n = 25), and patients ( n = 25). Results showed that communities were exposed to high risk factors for transmission of L. braziliensis . In logistic regression analysis, age was the only factor independently associated with having seen a CL/MCL lesion ( P = 0.002). The pervasive attitude in communities was that CL was not a problem. Treatment seeking was often delayed, partly due to secondary costs, and inappropriate remedies were applied. Several important cost-effective measures are indicated that may improve control of CL. Community awareness could be enhanced through existing community structures. Free supply of specific drugs should continue but ancillary support could be considered. Health professionals require routine and standardised provision of diagnosis and treatment algorithms for CL and MCL. During treatment, all patients could be given simple information to increase awareness in the community.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom